nnpNeurology, Neuropsychiatry, PsychosomaticsНеврология, нейропсихиатрия, психосоматика2074-27112310-1342"IMA-Press", LLC10.14412/2074-2711-2024-1S-72-80nnp-2387Research ArticleREVIEWОБЗОРTherapeutic potential of naproxen in common forms of headacheТерапевтический потенциал напроксена при распространенных формах головной болиhttps://orcid.org/0000-0002-3833-532XТабееваГ. Р.TabeevaG. R.

Гюзяль Рафкатовна Табеева

119021, Москва, ул. Россолимо, 11, стр. 1

Guzyal Rafkatovna Tabeeva

11, Rossolimo St., Build. 1, Moscow 119021

grtabeeva@gmail.comКафедра нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)РоссияDepartment of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)Russian Federation202419102024161SСпецвыпуск: Головная боль7280Copyright © Tabeeva G.R., 20242024Табеева Г.Р.Tabeeva G.R.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://nnp.ima-press.net/nnp/article/view/2387

The most common forms of headache (HA) in clinical practice are migraine, tension-type headache (TTH), cervicocranialgia and medication overuse headache. Modern strategies for the treatment of HA include the prescription of painkillers based on their efficacy, safety, experience of use, and patient's and physician's preference. Non-steroidal anti-inflammatory drugs are a universal mean of controlling HA, associated with a high analgesic potential that has been studied in almost all forms of cephalgia. Introduction to practice, confirmed efficacy and safety of Nalgesin® forte (naproxen) in observational studies in clinical practice make it the drug of choice for the most common forms of HA, among others.

Наиболее распространенными в клинической практике формами головной боли (ГБ) являются мигрень, головная боль напряжения (ГБН), цервикокраниалгии, лекарственно-индуцированная головная боль. Современные стратегии лечения ГБ предполагают назначение средств купирования с позиций их эффективности, безопасности, опыта применения, а также с учетом предпочтений пациентов и врачей. Нестероидные противовоспалительные препараты являются универсальными средствами контроля ГБ, что связано с высоким анальгетическим потенциалом, изученным практически при всех формах цефалгий. Опыт применения, подтвержденная эффективность и безопасность препарата Налгезин® форте (напроксен) в наблюдательных исследованиях в клинической практике делает его в том числе средством выбора при наиболее частых формах ГБ.

головная больмигреньголовная боль напряженияцервикокраниалгияболь в шеекупирование приступовнестероидные противовоспалительные препаратынапроксенНалгезин® фортеheadachemigrainetension headachecervicocranialgianeck painrelief of attacksnon-steroidal anti-inflammatory drugsnaproxenNalgesin® forteReferencesWorld Health Organization. Atlas of headache disorders and resources in the world 2011. A collaborative project of World Health Organization and Lifting The Burden; 2011. ISBN 9789241564212World Health Organization. Atlas of headache disorders and resources in the world 2011. A collaborative project of World Health Organization and Lifting The Burden; 2011. ISBN 9789241564212GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204-22. doi: 10.1016/S0140-6736(20)30925-9GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204-22. doi: 10.1016/S0140-6736(20)30925-9Latinovic R, Gulliford M, Ridsdale L. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):385-7. doi: 10.1136/jnnp.2005.073221Latinovic R, Gulliford M, Ridsdale L. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):385-7. doi: 10.1136/jnnp.2005.073221Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013 Mar;53(3):427-36. doi: 10.1111/head.12074Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013 Mar;53(3):427-36. doi: 10.1111/head.12074Green LA, Phillips RL, Fryer GE. The nature of primary medical care. In: Oxford Textbook of Primary Medical Care. Oxford, UK: Oxford University Press; 2005.Green LA, Phillips RL, Fryer GE. The nature of primary medical care. In: Oxford Textbook of Primary Medical Care. Oxford, UK: Oxford University Press; 2005.Becker LA, Iverson DC, Reed FM, et al. Study of Headache in North America in primary care. J R Coll Gen Pract. 1987 Sep;37(302):400-3.Becker LA, Iverson DC, Reed FM, et al. Study of Headache in North America in primary care. J R Coll Gen Pract. 1987 Sep;37(302):400-3.Genc H, Baykan B, Bolay H, et al; Head-MENAA study group. Cross-sectional, hospital-based analysis of headache types using ICHD-3 criteria in the Middle East, Asia, and Africa: the Head-MENAA study. J Headache Pain. 2023 Mar 13;24(1):24. doi: 10.1186/s10194-023-01555-8Genc H, Baykan B, Bolay H, et al; Head-MENAA study group. Cross-sectional, hospital-based analysis of headache types using ICHD-3 criteria in the Middle East, Asia, and Africa: the Head-MENAA study. J Headache Pain. 2023 Mar 13;24(1):24. doi: 10.1186/s10194-023-01555-8Jordan KP, Kadam UT, Hayward R, et al. Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord. 2010 Jul 2;11:144. doi: 10.1186/1471-2474-11-144Jordan KP, Kadam UT, Hayward R, et al. Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord. 2010 Jul 2;11:144. doi: 10.1186/1471-2474-11-144Стайнер ТДж, Пемелера К, Йенсен Р и др. Европейские принципы ведения пациентов с наиболее распространенными формами головной боли в общей практике. Практическое руководство для врачей: Пер. с англ. Москва: ООО «ОГГИ.РП»; 2010. 56 с.Steiner TJ, Paemeleire K, Jensen R, et al European principles of management of common headache disorders in primary care. Practical guide for doctors: Transl. from Eng. Moscow: LLC “OGGI.RP”; 2010. 56 p. (In Russ.).Табеева ГР. Головные боли в общеврачебной практике. Терапевтический архив. 2022;94(1):114-21. doi: 10.26442/00403660.2022.01.201325Tabeeva GR. Headaches in general medical practice. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(1):114-21. doi: 10.26442/00403660.2022.01.201325 (In Russ.).Ashina M, Buse DC, Ashina H, et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet. 2021 Apr 17;397(10283):1505-18. doi: 10.1016/S0140-6736(20)32342-4Ashina M, Buse DC, Ashina H, et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet. 2021 Apr 17;397(10283):1505-18. doi: 10.1016/S0140-6736(20)32342-4Steiner TJ, Jensen R, Katsarava Z, et al. Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain. 2019 May 21;20(1):57. doi: 10.1186/s10194-018-0899-2Steiner TJ, Jensen R, Katsarava Z, et al. Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain. 2019 May 21;20(1):57. doi: 10.1186/s10194-018-0899-2Phero JC, Dionne RA. Pharmacological management of head and neck pain. Otolaryngol Clin North Am. 2003 Dec;36(6):1171-85. doi: 10.1016/s0030-6665(03)00131-2Phero JC, Dionne RA. Pharmacological management of head and neck pain. Otolaryngol Clin North Am. 2003 Dec;36(6):1171-85. doi: 10.1016/s0030-6665(03)00131-2Парфенов ВА, Яхно НН, Кукушкин МЛ и др. Неспецифическая боль в шее (цервикалгия). Рекомендации Российского общества по изучению боли (РОИБ). Неврология, нейропсихиатрия, психосоматика. 2023;15(5):4-12. doi: 10.14412/2074-2711-2023-5-4-12Parfenov VA, Yakhno NN, Kukushkin ML, et al. Non-specific neck pain (cervicalgia). Guidelines of the Russian Society for the Study of Pain (RSSP). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(5):4-12. doi: 10.14412/2074-2711-2023-5-4-12 (In Russ.).Motola D, Vaccheri A, Silvani MC, et al. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur J Clin Pharmacol. 2004 Dec;60(10):731-8. doi: 10.1007/s00228-004-0826-0Motola D, Vaccheri A, Silvani MC, et al. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur J Clin Pharmacol. 2004 Dec;60(10):731-8. doi: 10.1007/s00228-004-0826-0Taylor FR, Kaniecki RG. Symptomatic treatment of migraine: when to use NSAIDs, triptans, or opiates. Curr Treat Options Neurol. 2011;13:15-27. doi: 10.1007/s11940-010-0107-4Taylor FR, Kaniecki RG. Symptomatic treatment of migraine: when to use NSAIDs, triptans, or opiates. Curr Treat Options Neurol. 2011;13:15-27. doi: 10.1007/s11940-010-0107-4Филатова ЕГ, Осипова ВВ, Табеева ГР и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):4-14. doi: 10.14412/2074-2711-2020-4-4-14Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Russian experts' recommendations. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4- 14. doi: 10.14412/2074-2711-2020-4-4-14 (In Russ.).Silberstein SD, Stirpe JC. COX inhibitors for the treatment of migraine. Expert Opin Pharmacother. 2014;15:1863-74. doi: 10.1517/14656566.2014.937704Silberstein SD, Stirpe JC. COX inhibitors for the treatment of migraine. Expert Opin Pharmacother. 2014;15:1863-74. doi: 10.1517/14656566.2014.937704Bendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tension-type headache – report of an EFNS task force. Eur J Neurol. 2010;17:1318-25. doi: 10.1111/j.1468-1331.2010.03070.xBendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tension-type headache – report of an EFNS task force. Eur J Neurol. 2010;17:1318-25. doi: 10.1111/j.1468-1331.2010.03070.xWrobel Goldberg S, Silberstein S, Grosberg BM. Considerations in the treatment of tension-type headache in the elderly. Drugs Aging. 2014;31:797-804. doi: 10.1007/s40266-014-0220-2Wrobel Goldberg S, Silberstein S, Grosberg BM. Considerations in the treatment of tension-type headache in the elderly. Drugs Aging. 2014;31:797-804. doi: 10.1007/s40266-014-0220-2Diener HC. Headache: insight, understanding, treatment and patient management. Int J Clin Pract Suppl. 2013;178:33-6. doi: 10.1111/ijcp.12049Diener HC. Headache: insight, understanding, treatment and patient management. Int J Clin Pract Suppl. 2013;178:33-6. doi: 10.1111/ijcp.12049Affaitati G, Martelletti P, Lopopolo M, et al. Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache. Pain Pract. 2017 Mar;17(3):392-401. doi: 10.1111/papr.12461Affaitati G, Martelletti P, Lopopolo M, et al. Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache. Pain Pract. 2017 Mar;17(3):392-401. doi: 10.1111/papr.12461Levy D, Zhang XC, Jakubowski M, Burstein R. Sensitization of meningeal nociceptors: inhibition by naproxen. Eur J Neurosci. 2008 Feb;27(4):917-22. doi: 10.1111/j.1460-9568.2008.06068.xLevy D, Zhang XC, Jakubowski M, Burstein R. Sensitization of meningeal nociceptors: inhibition by naproxen. Eur J Neurosci. 2008 Feb;27(4):917-22. doi: 10.1111/j.1460-9568.2008.06068.xPardutz A, Schoenen J. NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data. Pharmaceuticals (Basel). 2010 Jun 17;3(6):1966- 87. doi: 10.3390/ph3061966Pardutz A, Schoenen J. NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data. Pharmaceuticals (Basel). 2010 Jun 17;3(6):1966- 87. doi: 10.3390/ph3061966Zhang XC, Kainz V, Jakubowski M, et al. Localization of COX-1 and COX-2 in the intracranial dura mater of the rat. Neurosci Lett. 2009 Mar 6;452(1):33-6. doi: 10.1016/j.neulet.2009.01.032Zhang XC, Kainz V, Jakubowski M, et al. Localization of COX-1 and COX-2 in the intracranial dura mater of the rat. Neurosci Lett. 2009 Mar 6;452(1):33-6. doi: 10.1016/j.neulet.2009.01.032Ebersberger A, Averbeck B, Messlinger K, Reeh PW. Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience. 1999 Mar;89(3):901-7. doi: 10.1016/s0306-4522(98)00366-2Ebersberger A, Averbeck B, Messlinger K, Reeh PW. Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience. 1999 Mar;89(3):901-7. doi: 10.1016/s0306-4522(98)00366-2Beiche F, Scheuerer S, Brune K, et al. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 1996 Jul 22;390(2):165-9. doi: 10.1016/0014-5793(96)00604-7Beiche F, Scheuerer S, Brune K, et al. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 1996 Jul 22;390(2):165-9. doi: 10.1016/0014-5793(96)00604-7Goppelt-Struebe M, Beiche F. Cyclooxygenase-2 in the spinal cord: localization and regulation after a peripheral inflammatory stimulus. Adv Exp Med Biol. 1997;433:213- 6. doi: 10.1007/978-1-4899-1810-9-45Goppelt-Struebe M, Beiche F. Cyclooxygenase-2 in the spinal cord: localization and regulation after a peripheral inflammatory stimulus. Adv Exp Med Biol. 1997;433:213- 6. doi: 10.1007/978-1-4899-1810-9-45Yang GY, Lee MK, Bae YC, Ahn DK. Intracisternal administration of COX inhibitors attenuates mechanical allodynia following compression of the trigeminal ganglion in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):589-95. doi: 10.1016/j.pnpbp.2009.02.010. Epub 2009 Feb 23.Yang GY, Lee MK, Bae YC, Ahn DK. Intracisternal administration of COX inhibitors attenuates mechanical allodynia following compression of the trigeminal ganglion in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):589-95. doi: 10.1016/j.pnpbp.2009.02.010. Epub 2009 Feb 23.Diener HC. Positron emission tomography studies in headache. Headache. 1997 Nov- Dec;37(10):622-5. doi: 10.1046/j.1526-4610.1997.3710622.xDiener HC. Positron emission tomography studies in headache. Headache. 1997 Nov- Dec;37(10):622-5. doi: 10.1046/j.1526-4610.1997.3710622.xBreder CD, Smith WL, Raz A, et al. Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J Comp Neurol. 1992 Aug 15;322(3):409-38. doi: 10.1002/cne.903220309Breder CD, Smith WL, Raz A, et al. Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J Comp Neurol. 1992 Aug 15;322(3):409-38. doi: 10.1002/cne.903220309Breder CD, Dewitt D, Kraig RP. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol. 1995 May 1;355(2):296-315. doi: 10.1002/cne.903550208Breder CD, Dewitt D, Kraig RP. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol. 1995 May 1;355(2):296-315. doi: 10.1002/cne.903550208Shin MC, Jang MH, Chang HK, et al. Modulation of cyclooxygenase-2 on glycineand glutamate-induced ion currents in rat periaqueductal gray neurons. Brain Res Bull. 2003 Jan 15;59(4):251-6. doi: 10.1016/s0361-9230(02)00872-9Shin MC, Jang MH, Chang HK, et al. Modulation of cyclooxygenase-2 on glycineand glutamate-induced ion currents in rat periaqueductal gray neurons. Brain Res Bull. 2003 Jan 15;59(4):251-6. doi: 10.1016/s0361-9230(02)00872-9Vaughan CW. Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones. Br J Pharmacol. 1998 Apr;123(8):1479-81. doi: 10.1038/sj.bjp.0701818Vaughan CW. Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones. Br J Pharmacol. 1998 Apr;123(8):1479-81. doi: 10.1038/sj.bjp.0701818Leith JL, Wilson AW, Donaldson LF, Lumb BM. Cyclooxygenase-1-derived prostaglandins in the periaqueductal gray differentially control C- versus A-fiber-evoked spinal nociception. J Neurosci. 2007 Oct 17;27(42):11296-305. doi: 10.1523/JNEU-ROSCI.2586-07.2007Leith JL, Wilson AW, Donaldson LF, Lumb BM. Cyclooxygenase-1-derived prostaglandins in the periaqueductal gray differentially control C- versus A-fiber-evoked spinal nociception. J Neurosci. 2007 Oct 17;27(42):11296-305. doi: 10.1523/JNEU-ROSCI.2586-07.2007Bolay H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002 Feb;8(2):136-42. doi: 10.1038/nm0202-136Bolay H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002 Feb;8(2):136-42. doi: 10.1038/nm0202-136Capone ML, Tacconelli S, Sciulli MG, et al. Human pharmacology of naproxen sodium. J Pharmacol Exp Ther. 2007 Aug;322(2):453-60. doi: 10.1124/jpet.107.122283. Epub 2007 May 1.Capone ML, Tacconelli S, Sciulli MG, et al. Human pharmacology of naproxen sodium. J Pharmacol Exp Ther. 2007 Aug;322(2):453-60. doi: 10.1124/jpet.107.122283. Epub 2007 May 1.DeArmond B, Francisco CA, Lin JS, et al. Safety profile of over-the-counter naproxen sodium. Clin Ther. 1995 Jul-Aug;17(4):587-601; discussion 586. doi: 10.1016/0149-2918(95)80036-0DeArmond B, Francisco CA, Lin JS, et al. Safety profile of over-the-counter naproxen sodium. Clin Ther. 1995 Jul-Aug;17(4):587-601; discussion 586. doi: 10.1016/0149-2918(95)80036-0Sevelius H, Runkel R, Segre E, Bloomfield SS. Bioavailability of naproxen sodium and its relationship to clinical analgesic effects. Br J Clin Pharmacol. 1980 Sep;10(3):259-63. doi: 10.1111/j.1365-2125.1980.tb01753.xSevelius H, Runkel R, Segre E, Bloomfield SS. Bioavailability of naproxen sodium and its relationship to clinical analgesic effects. Br J Clin Pharmacol. 1980 Sep;10(3):259-63. doi: 10.1111/j.1365-2125.1980.tb01753.xTfelt-Hansen P, Rolan P. Nonsteroidal anti-inflammatory drugs in the acute treatment of migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. P. 449-57.Tfelt-Hansen P, Rolan P. Nonsteroidal anti-inflammatory drugs in the acute treatment of migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. P. 449-57.Weisman SM, Ciavarra G, Cooper G. What a pain in the … back: a review of current treatment options with a focus on naproxen sodium. J Pharm Pharm Sci. 2024 Feb 7;27:12384. doi: 10.3389/jpps.2024.12384Weisman SM, Ciavarra G, Cooper G. What a pain in the … back: a review of current treatment options with a focus on naproxen sodium. J Pharm Pharm Sci. 2024 Feb 7;27:12384. doi: 10.3389/jpps.2024.12384Johnson ES, Ratcliffe DM, Wilkinson M. Naproxen sodium in the treatment of migraine. Cephalalgia. 1985 Mar;5(1):5-10. doi: 10.1046/j.1468-2982.1985.0501005.xJohnson ES, Ratcliffe DM, Wilkinson M. Naproxen sodium in the treatment of migraine. Cephalalgia. 1985 Mar;5(1):5-10. doi: 10.1046/j.1468-2982.1985.0501005.xNestvold K, Kloster R, Partinen M, Sulkava R. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia. 1985 Jun;5(2):115-9. doi: 10.1046/j.1468-2982.1985.0502115.xNestvold K, Kloster R, Partinen M, Sulkava R. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia. 1985 Jun;5(2):115-9. doi: 10.1046/j.1468-2982.1985.0502115.xSuthisisang CC, Poolsup N, Suksomboon N, et al. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache. 2010 May;50(5):808-18. doi: 10.1111/j.1526-4610.2010.01635.x. Epub 2010 Mar 5.Suthisisang CC, Poolsup N, Suksomboon N, et al. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache. 2010 May;50(5):808-18. doi: 10.1111/j.1526-4610.2010.01635.x. Epub 2010 Mar 5.Клинические рекомендации. Мигрень у взрослых. Доступно по ссылке: https://cr.minzdrav.gov.ru/recomend/295Clinical guidelines. Migraine in adults. Available at: https://cr.minzdrav.gov.ru/recomend/295 (In Russ.).Табеева ГР, Амелин АВ, Ахмадеева ЛР и др. Оптимизация купирования приступов мигрени. Неврология, нейропсихиатрия, психосоматика. 2023;15(2):126-33. doi: 10.14412/2074-2711-2023-2-126-133Tabeeva GR, Amelin AV, Akhmadeeva LR, et al. Optimization of migraine attacks relief. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(2):126-33. doi: 10.14412/2074-2711-2023-2-126-133 (In Russ.).Blumenfeld A, Gennings C, Cady R. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6.Blumenfeld A, Gennings C, Cady R. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6.Клинические рекомендации. Головная боль напряжения у взрослых. Доступно по ссылке: https://cr.minzdrav.gov.ru/recomend/162Clinical guidelines. Tension headache in adults. Available at: https://cr.minzdrav.gov.ru/recomend/162 (In Russ.).Prior MJ, Cooper KM, May LG, Bowen DL. Efficacy and safety of acetaminophen and naproxen in the treatment of tensiontype headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia. 2002 Nov;22(9):740-8. doi: 10.1046/j.1468-2982.2002.00419.xPrior MJ, Cooper KM, May LG, Bowen DL. Efficacy and safety of acetaminophen and naproxen in the treatment of tensiontype headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia. 2002 Nov;22(9):740-8. doi: 10.1046/j.1468-2982.2002.00419.xMiller DS, Talbot CA, Simpson W, Korey A. A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache. 1987 Jul;27(7):392-6. doi: 10.1111/j.1526-4610.1987.hed2707392.xMiller DS, Talbot CA, Simpson W, Korey A. A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache. 1987 Jul;27(7):392-6. doi: 10.1111/j.1526-4610.1987.hed2707392.xCashin AG, Wand BM, O'Connell NE, et al. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2023 Apr 4;4(4):CD013815. doi: 10.1002/14651858.CD013815.pub2Cashin AG, Wand BM, O'Connell NE, et al. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2023 Apr 4;4(4):CD013815. doi: 10.1002/14651858.CD013815.pub2Corp N, Mansell G, Stynes S, et al. Evidence-based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines. Eur J Pain. 2021 Feb;25(2):275-95. doi: 10.1002/ejp.1679Corp N, Mansell G, Stynes S, et al. Evidence-based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines. Eur J Pain. 2021 Feb;25(2):275-95. doi: 10.1002/ejp.1679Wong JJ, Cote P, Ameis A, et al. Are nonsteroidal anti-inflammatory drugs effective for the management of neck pain and associated disorders, whiplash-associated disorders, or non-specific low back pain? A systematic review of systematic reviews by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur Spine J. 2016 Jan;25(1):34- 61. doi: 10.1007/s00586-015-3891-4Wong JJ, Cote P, Ameis A, et al. Are nonsteroidal anti-inflammatory drugs effective for the management of neck pain and associated disorders, whiplash-associated disorders, or non-specific low back pain? A systematic review of systematic reviews by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur Spine J. 2016 Jan;25(1):34- 61. doi: 10.1007/s00586-015-3891-4Левин ОС, Скоромец АА, Табеева ГР и др. Эффективность и безопасность напроксена в лечении неспецифической люмбалгии: результаты открытого многоцентрового исследования. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(5):27-31. doi: 10.17116/jnevro201911905127Levin OS, Skoromets AA, Tabeeva GR, et al. The efficacy and safety of naproxen in the treatment of nonspecific lumbalgia: the results of an open multi-center study (NEST). Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(5):27-31. (In Russ.).Парфенов ВА. Терапевтические исходы у пациентов с острой неспецифической (скелетно-мышечной) болью, по данным наблюдательного исследования ФОРТЕ. Неврология, нейропсихиатрия, психосоматика. 2024;16(3):88-95. doi: 10.14412/2074-2711-2024-3-88-95Parfenov VA. Therapeutic outcomes in patients with acute non-specific (musculoskeletal) pain according to the FORTE (ФОРТЕ) observational study. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(3):88-95. doi: 10.14412/2074-2711-2024-3-88-95 (In Russ.).Шестель ЕА, Данилов АБ. Боли в шее у лиц пожилого возраста. РМЖ. Болевой синдром. 2015;29:19-21.Shestel EA, Danilov AB. Neck pain in the elderly. RMJ. Pain syndrome. 2015;29:19- 21 (In Russ.).Bansal V, Dex T, Proskin H, Garreffa S. A look at the safety profile of over-the-counter naproxen sodium: a meta-analysis. J Clin Pharmacol. 2001 Feb;41(2):127-38. doi: 10.1177/00912700122009935Bansal V, Dex T, Proskin H, Garreffa S. A look at the safety profile of over-the-counter naproxen sodium: a meta-analysis. J Clin Pharmacol. 2001 Feb;41(2):127-38. doi: 10.1177/00912700122009935Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD004234. doi: 10.1002/14651858.CD004234.pub3Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD004234. doi: 10.1002/14651858.CD004234.pub3Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative metaanalysis. BMJ. 1996 Jun 22;312(7046):1563-6. doi: 10.1136/bmj.312.7046.1563Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative metaanalysis. BMJ. 1996 Jun 22;312(7046):1563-6. doi: 10.1136/bmj.312.7046.1563Каратеев АЕ. Напроксен: универсальный анальгетик с минимальным риском кардиоваскулярных осложнений. Современная ревматология. 2016;10(2):70-7. doi: 10.14412/1996-7012-2016-2-70-77Karateev AE. Naproxen: A universal analgesic with a minimal risk of cardiovascular events. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2016;10(2):70-7. doi: 10.14412/1996-7012-2016-2-70-77 (In Russ.).Kyeremateng K, Troullos E, Paredes-Diaz A. Safety of naproxen compared with placebo, ibuprofen and acetaminophen: a pooled analysis of eight multiple-dose, short-term, randomized controlled studies. Curr Med Res Opin. 2019 Oct;35(10):1671-6. doi: 10.1080/03007995.2019.1612338 . Epub 2019 Jun 5.Kyeremateng K, Troullos E, Paredes-Diaz A. Safety of naproxen compared with placebo, ibuprofen and acetaminophen: a pooled analysis of eight multiple-dose, short-term, randomized controlled studies. Curr Med Res Opin. 2019 Oct;35(10):1671-6. doi: 10.1080/03007995.2019.1612338 . Epub 2019 Jun 5.Mehuys E, Paemeleire K, Van Hees T, et al. Selfmedication of regular headache: a community pharmacy-based survey. Eur J Neurol. 2012;19:1093-9 doi: 10.1111/j.1468-1331.2012.03681.xMehuys E, Paemeleire K, Van Hees T, et al. Selfmedication of regular headache: a community pharmacy-based survey. Eur J Neurol. 2012;19:1093-9 doi: 10.1111/j.1468-1331.2012.03681.xТабеева ГР. Проблемы выбора эффективного обезболивания при мигрени. Неврология, нейропсихиатрия, психосоматика. 2023;15(5):109-16. doi: 10.14412/2074-2711-2023-5-109-116 .Tabeeva GR. Problems in the selection of effective analgesics for migraine. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(5):109-16. doi: 10.14412/2074-2711-2023-5-109-116 (In Russ.).Welch KM, Ellis DJ, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology. 1985 Sep;35(9):1304-10. doi: 10.1212/wnl.35.9.1304Welch KM, Ellis DJ, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology. 1985 Sep;35(9):1304-10. doi: 10.1212/wnl.35.9.1304Ziegler DK, Ellis DJ. Naproxen in prophylaxis of migraine. Arch Neurol. 1985 Jun;42(6):582-4. doi: 10.1001/arch-neur.1985.04060060084014Ziegler DK, Ellis DJ. Naproxen in prophylaxis of migraine. Arch Neurol. 1985 Jun;42(6):582-4. doi: 10.1001/arch-neur.1985.04060060084014Табеева ГР, Косивцова ОВ, Ковальчук НА, Орлюк ТА. Рефрактерная мигрень. Неврология, нейропсихиатрия, психосоматика. 2024;16(2):76-86. doi: 10.14412/2074-2711-2024-2-76-86Tabeeva GR, Kosivtsova OV, Kovalchuk NA, Orlyuk TA. Refractory migraine. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(2):76- 86. doi: 10.14412/2074-2711-2024-2-76-86 (In Russ.).Sances G, Martignoni E, Fioroni L, et al. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache. 1990 Nov;30(11):705-9. doi: 10.1111/j.1526-4610.1990.hed3011705.xSances G, Martignoni E, Fioroni L, et al. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache. 1990 Nov;30(11):705-9. doi: 10.1111/j.1526-4610.1990.hed3011705.xAllais G, Bussone G, De Lorenzo C, et al. Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations. Neurol Sci. 2007 May;28 Suppl 2:S225-8. doi: 10.1007/s10072-007-0783-3Allais G, Bussone G, De Lorenzo C, et al. Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations. Neurol Sci. 2007 May;28 Suppl 2:S225-8. doi: 10.1007/s10072-007-0783-3

The authors declare that there are no conflicts of interest present.